Eraflu Indications/Uses

Treatment of influenza: Eraflu is indicated in adults and adolescents 13 years and over who present with symptoms typical of influenza, when influenza virus is circulating in the community. Efficacy has been demonstrated when treatment is initiated within two days of first onset of symptoms.
Prevention of influenza: Post-exposure prevention in adults and adolescents 13 years and over following contact with a clinically diagnosed influenza case when influenza virus is circulating in the community.
Eraflu is not a substitute for influenza vaccination.
The use of antivirals for the treatment and prevention of influenza should be determined on the basis of official recommendations. Decisions regarding the use of oseltamivir for treatment and prophylaxis should take into consideration what is known about the characteristics of the circulating influenza viruses, available information on influenza drug susceptibility patterns for each season and the impact of the disease in different geographical areas and patient populations.